(Q37738488)

22 August 2017

1 reference

title

Treatment of pediatric acute lymphoblastic leukemia: progress achieved and challenges remaining (English)

1 reference

22 August 2017

1 reference

lymphoblastic leukemia

1 reference

1

Paul S Gaynon

1 reference

22 August 2017

publication date

1 July 2007

1 reference

Current hematologic malignancy reports

22 August 2017

published in

1 reference

22 August 2017

volume

2

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

193-201

1 reference

https://scigraph.springernature.com/pub.10.1007/s11899-007-0026-y

22 August 2017

exact match

0 references

cites work

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).

1 reference

12 December 2020

Preponderant mitotic activity of nonleukemic cells plays an important role in failures to detect abnormal clone in childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital

1 reference

12 December 2020

Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL).

1 reference

12 December 2020

Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Comparison of multidimensional flow cytometry with standard morphology for evaluation of early marrow response in pediatric acute lymphoblastic leukemia

1 reference

12 December 2020

Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995.

1 reference

12 December 2020

The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia

1 reference

12 December 2020

Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised children

1 reference

12 December 2020

Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia

1 reference

12 December 2020

Cancer statistics, 2005

1 reference

12 December 2020

Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: "folate overrescue" concept revisited

1 reference

12 December 2020

Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2

1 reference

12 December 2020

Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review

1 reference

12 December 2020

Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party.

1 reference

12 December 2020

Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia study group.

1 reference

12 December 2020

Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus

1 reference

12 December 2020

Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia

1 reference

12 December 2020

Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial

1 reference

12 December 2020

MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen

1 reference

12 December 2020

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

1 reference

12 December 2020

Thioguanine offers no advantage over mercaptopurine in maintenance treatment of childhood ALL: results of the randomized trial COALL-92.

1 reference

12 December 2020

Non-randomised study comparing toxicity of Escherichia coli and Erwinia asparaginase in children with leukaemia

1 reference

12 December 2020

Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen

1 reference

12 December 2020

Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia

1 reference

12 December 2020

Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial

1 reference

12 December 2020

Prolonged second remissions in childhood acute lymphocytic leukemia: a report from the Childrens Cancer Study Group

1 reference

12 December 2020

Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months

1 reference

12 December 2020

Intensification of mercaptopurine/methotrexate maintenance chemotherapy may increase the risk of relapse for some children with acute lymphoblastic leukemia

1 reference

12 December 2020

Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia

1 reference

12 December 2020

The ninth annual david karnofsky lecture.Treatment of acute lymphocytic leukemia

1 reference

12 December 2020

Pathways through relapses and deaths of children with acute lymphoblastic leukemia: role of allogeneic stem-cell transplantation in Nordic data

1 reference

12 December 2020

Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: comparison of 1800 rad and 2400 rad. A report for Children's Cancer Study Group

1 reference

12 December 2020

Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic l

1 reference

12 December 2020

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

12 December 2020

Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study.

1 reference

12 December 2020

Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood)

1 reference

12 December 2020

Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL.

1 reference

12 December 2020

Asparaginase-methotrexate in combination chemotherapy: schedule-dependent differential effects on normal versus neoplastic cells.

1 reference

12 December 2020

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse

1 reference

12 December 2020

Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia

1 reference

12 December 2020

Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment

1 reference

12 December 2020

Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocols

1 reference

12 December 2020

Comparison of three methods of central-nervous-system prophylaxis in childhood acute lymphoblastic leukaemia

1 reference

12 December 2020

Asparaginase pharmacodynamics differ by formulation among children with newly diagnosed acute lymphoblastic leukemia

1 reference

12 December 2020

Evolution of BFM trials for childhood ALL.

1 reference

12 December 2020

Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.

1 reference

12 December 2020

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

12 December 2020

Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study

1 reference

12 December 2020

No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol

1 reference

12 December 2020

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

1 reference

12 December 2020

Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial

1 reference

12 December 2020

Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial

1 reference

12 December 2020

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia

1 reference

12 December 2020

Clinical relevance of MRD in children undergoing allogeneic stem cell transplantation for ALL.

1 reference

12 December 2020

Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial

1 reference

12 December 2020

Outcome after first relapse in childhood acute lymphoblastic leukaemia - lessons from the United Kingdom R2 trial

1 reference

12 December 2020

Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia

1 reference

12 December 2020

Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)

1 reference

12 December 2020

Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.

1 reference

12 December 2020

High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Mar

1 reference

12 December 2020

PCR assessment of bone marrow status in ‘isolated’extramedullary relapse of childhood B-precursor acute lymphoblastic leukaemia

1 reference

12 December 2020

Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

1 reference

12 December 2020

Molecular evidence for minimal residual bone marrow disease in children with 'isolated' extra-medullary relapse of T-cell acute lymphoblastic leukemia

1 reference

12 December 2020

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

1 reference

12 December 2020

Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia.

1 reference

12 December 2020

Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies.

1 reference

12 December 2020

Childhood leukemia as a model for cancer research: the Richard and Hinda Rosenthal Foundation Award Lecture

1 reference

12 December 2020

Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811). The Japanese Children's Cancer and Leukemia Study Group

1 reference

12 December 2020

A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

1 reference

12 December 2020

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

1 reference

12 December 2020

[Which is the best methotrexate schedule for maintenance therapy of childhood ALL? A randomized study]

1 reference

12 December 2020

The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia

1 reference

12 December 2020

Schedule-dependent synergism and antagonism between methotrexate and cytarabine against human leukemia cell lines in vitro.

1 reference

12 December 2020

10.1007/S11899-007-0026-Y

Identifiers

DOI

1 reference

22 August 2017

1 reference